POST Online Media Lite Edition


Incyte Corporation appoints Jacqualyn A. Fouse to board

Staff Writer |
Wilmington, De., USA - October 31, 2017, Wilmington, De., USA - Incyte Corporation, a pharmaceutical company, announced the appointment of Jacqualyn A. Fouse as a new member of the board of directors, effective November 14, 2017.

Article continues below

Dr. Fouse is currently the Executive Chair of Dermavant Sciences, a position she has held since July 2017.

Prior to joining Dermavant, Dr. Fouse served in various senior capacities at Celgene Corporation, most recently as Strategic Advisor to the Management Executive Committee.

Dr. Fouse's previous roles at Celgene included President and Chief Operating Officer; President, Hematology and Oncology; and Chief Financial Officer.

Prior to joining Celgene, she served as Chief Financial Officer of Bunge Limited, and was previously Chief Financial Officer and Head of Corporate Strategy at Alcon Laboratories, Inc.

Dr. Fouse currently serves as a Director of Dick’s Sporting Goods, Inc.


What to read next

Jacqualyn A. Fouse new CFO at The Perrigo Company
Celgene Corporation COO Jacqualyn Fouse to retire
Incyte Corporation: Wendy Dixon new director